http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2015252137-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e7e4ea0444d7d1af1da630a97fb419a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2015-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54a9aa6ec769ae6bd54158d037546e0f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f71ee8b2ca706eba75b3088647d983fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb6e064aba336604e01c76c4610569f0 |
| publicationDate | 2016-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2015252137-B2 |
| titleOfInvention | Compositions and methods for diagnosing and treating kidney disorders in a feline |
| abstract | The present invention provides a method of diagnosing the existence of a kidney disorder in a feline comprising measuring the level of expression of one or more biomarkers selected from the group consisting of lumican; collagen alpha 1(III) chain, variant 12; decorin; secreted frizzled-related protein 2; retinol binding protein 5; MMP-2; MMP-7; and MMP-19, in a biological sample from the feline, wherein differences in expression of the one or more biomarkers in the sample relative to a control value for expression in a sample from a normal animal indicate the existence of a kidney disorder; a method of treating a feline so diagnosed; and compositions, reagents and kits for carrying out the specified methods. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018140957-A1 |
| priorityDate | 2011-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 192.